Phytoestrogens and coronary microvascular function in women with suspected myocardial ischemia: A report from the Women's Ischemia Syndrome Evaluation (WISE) study

Journal of Women's Health

Volumn 16, Issue 4, 2007, Pages 481-488

  Pepine, Carl J ^a   Von Mering, Gregory O ^a   Kerensky, Richard A ^a   Johnson, B Delia ^b   McGorray, Susan P ^a   Kelsey, Sheryl F ^c   Pohost, Gerald ^d   Rogers, William J ^e   Reis, Steven E ^c   Sopko, George ^f   Merz, C Noel Bairey ^g  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

^c UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^d UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^e University of Alabama at Birmingham   (United States)

^f NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

^g CEDARS SINAI MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCHOLINE; DAIDZEIN; ESTRADIOL; GENISTEIN; GLYCERYL TRINITRATE; PHYTOESTROGEN;

ADULT; AGED; ANGIOCARDIOGRAPHY; ANGIOGRAPHY; ARTICLE; BLOOD FLOW; CLINICAL FEATURE; CORONARY ARTERY DISEASE; DISEASE SEVERITY; DRUG BLOOD LEVEL; FEMALE; HEART CONTRACTION; HEART MUSCLE ISCHEMIA; HUMAN; POSTMENOPAUSE; PRIORITY JOURNAL;

ACETYLCHOLINE; ADENOSINE; ADULT; AGED; BLOOD FLOW VELOCITY; CORONARY ANGIOGRAPHY; CORONARY ARTERIOSCLEROSIS; CORONARY VESSELS; ESTRADIOL; FEMALE; GENISTEIN; HUMANS; ISOFLAVONES; MIDDLE AGED; MYOCARDIAL ISCHEMIA; NITROGLYCERIN; PHYTOESTROGENS; PREDICTIVE VALUE OF TESTS;

EID: 34250719083     PISSN: 15409996     EISSN: None     Source Type: Journal    
DOI: 10.1089/jwh.2006.0104     Document Type: Article

References (37)

1. Clarkson TB, Anthony MS. Phytoestrogens and coronary heart disease. Baillieres Clin Endocrinol Metab 1998;12:589.
2. Tikkanen MJ, Adlercreutz H. Dietary soy-derived isoflavone phytoestrogens. Could they have a role in coronary heart disease prevention? Biochem Pharmacol 2000;60:1.
3. Glazier MG, Bowman MA. A review of the evidence for the use of phytoestrogens as a replacement for traditional estrogen replacement therapy. Arch Intern Med 2001;161:1161.
4. Nagata C, Takatsuka N, Kawakami N, Shimizu H. Soy product intake and hot flashes in Japanese women: Results from a community-based prospective study. Am J Epidemiol 2001;153:790.
5. Lissin LW, Cooke JP. Phytoestrogens and cardiovascular health. J Am Coll Cardiol 2000;35:1403.
6. Teede HJ, Dalais FS, Kotsopoulos D, Liang YL, Davis S, McGrath BP. Dietary soy has both beneficial and potentially adverse cardiovascular effects: A placebo-controlled study in men and postmenopausal women. J Clin Endocrinol Metab 2001;86:3053.
7. Honore EK, Williams JK, Anthony MS, Clarkson TB. Soy isoflavones enhance coronary vascular reactivity in atherosclerotic female macaques. Fertil Steril 1997;67:148.
8. Steinberg FM, Guthrie NL, Villablanca AC, Kumar K, Murray MJ. Soy protein with isoflavones has favorable effects on endothelial function that are independent of lipid and antioxidant effects in healthy postmenopausal women. Am J Clin Nutr 2003;78:123.
9. Hale G, Paul-Labrador M, Dwyer JH, Bairey Merz CN. Isoflavone supplementation and endothelial function in menopausal women. Clin Endocrinol 2002;56:693.
10. Kreijkamp-Kaspers S, Kok L, Bots ML, Grobbee DE, van der Schouw YT. Dietary phytoestrogens and vascular function in postmenopausal women: A cross-sectional study. J Hypertens 2004;22:1381.
11. Simons LA, von Konigsmark M, Simons J, Celermajer DS. Phytoestrogens do not influence lipoprotein levels or endothelial function in healthy, postmenopausal women. Am J Cardiol 2000;85:1297.
12. Yellayi S, Naaz A, Szewczykowski MA, et al. The phytoestrogen genistein induces thymic and immune changes: A human health concern? Proc Natl Acad Sci USA 2002;99:7616.
13. Saitta A, Altavilla D, Cucinotta D, et al. Randomized, double-blind, placebo-controlled study on effects of raloxifene and hormone replacement therapy on plasma NO concentrations, endothelin-1 levels, and endothelium-dependent vasodilation in postmenopausal women. Arterioscler Thromb Vasc Biol 2001;21:1512.
14. Higashi Y, Sanada M, Sasaki S, et al. Effect of estrogen replacement therapy on endothelial function in peripheral resistance arteries in normotensive and hypertensive postmenopausal women. Hypertension 2001;37:651.
15. Herrington DM, Braden GA, Williams JK, Morgan TM. Endothelial-dependent coronary vasomotor responsiveness in postmenopausal women with and without estrogen replacement therapy. Am J Cardiol 1994;73:951.
16. Guzic-Salobir B, Keber I, Seljeflot I, Arnesen H, Vrabic L. Combined hormone replacement therapy improves endothelial function in healthy postmenopausal women. J Intern Med 2001;250:508.
17. Merz CN, Kelsey SF, Pepine CJ, et al. The Women's Ischemia Syndrome Evaluation (WISE) study: Protocol design, methodology, and feasibility report. J Am Coll Cardiol 1999;33:1453.
18. Reis SE, Holubkov R, Lee JS, et al. Coronary flow velocity response to adenosine characterizes coronary microvascular function in women with chest pain and no obstructive coronary disease: Results from the pilot phase of the Women's Ischemia Syndrome Evaluation (WISE) study. J Am Coll Cardiol 1999;33:1469.
19. Zeiher AM, Drexler H, Wollschlager H, Just H. Modulation of coronary vasomotor tone in humans: Progressive endothelial dysfunction with different early stages of coronary atherosclerosis. Circulation 1991; 83:391.
20. Hasdai D, Gibbons RJ, Holmes DR Jr, Higano ST, Lerman A. Coronary endothelial dysfunction in humans is associated with myocardial perfusion defects. Circulation 1997;96:3390.
21. Harrison DG, Bates JN. The nitrovasodilators: New ideas about old drugs. Circulation 1993;87:1461.
22. Doucette JW, Corl PD, Payne HM, et al. Validation of a Doppler guidewire for intravascular measurement of coronary artery flow velocity. Circulation 1992; 85:1899.
23. Sharaf B, Pepine CJ, Reis S, et al. Detailed angiographic analysis of women presenting with suspected ischemic chest pain: Pilot phase data from the NHLBI-sponsored Women's Ischemia Syndrome Evaluation (WISE) study angiographic core laboratory Am J Cardiol 2001;87:937.
24. Coward L, Kirk K, Albin N, Barnes S. Analysis of plasma isoflavones by reverse phase HPLC multiple reaction ion monitoring mass spectrometry. Clin Chem Acta 1996;247:121.
25. Hale GE, Hughes CL, Robboy SJ, Agarwal SK, Bievre M. A double-blind randomized study on the effects of red clover isoflavones on the endometrium. Menopause 2001;8:338.
26. Bairey Merz CN, Johnson BD, Braunstein GD, Pepine CJ, Reis SE, Paul-Labrador M, Hale G, Sharaf BL, Bittner V, Sopko G, Kelsey SF, for the Women's Ischemia Syndrome Evaluation Study Group. Phytoestrogens and lipoproteins in women. J Clin Endorinol Metab 2006;91:2209.
27. Fotsis T, Pepper M, Adlercreutz H, et al. Genistein, a dietary-derived inhibitor of in vitro angiogenesis. Proc Natl Acad Sci USA 1993;90:2690.
28. Walker HA, Dean TS, Sanders TA, Jackson G, Ritter JM, Chowienczyk PJ. The phytoestrogen genistein produces acute nitric oxide-dependent dilation of human forearm vasculature with similar potency to 17SS-estradiol. Circulation 2001;103:258.
29. Anderson JW, Johnstone BM, Book-Newell ME. Meta-analysis of the effects of soy protein intake on serum lipids. N Engl J Med 1995;333:276.
30. Anthony MS, Clarkson K, Hughes CL Jr, Morgan TM, Burke GL. Soybean isoflavones improve cardiovascular risk factors without affecting the reproductive system of peripubertal rhesus monkeys. J Nutr 1996; 126:43.
31. Washburn S, Burke GL, Morgan T, Anthony M. Effect of soy protein supplementation on serum lipoproteins, blood pressure, and menopausal symptoms in perimenopausal women. Menopause 1999;6:7.
32. Crouse JR, Morgan T, Terry JG, Ellis J, Vitolins M, Vurke GL. A randomized trial comparing the effect of casein with that of soy protein containing varying amounts of isoflavones on plasma concentrations of lipids and lipoproteins. Arch Intern Med 1999;159: 2070.
33. Potter SM, Bakhit RM, Esses-Sorlie DL, et al. Depression of plasma cholesterol in men by consumption of baked products containing soy protein. Am J Clin Nutr 1993;58:501.
34. Teixeira SR, Potter SM, Weigel R, Hannum S, Erdman JW, Hasler CM. Effects of feeding 4 levels of soy protein for 3 and 6 wk on blood lipids and apolipoproteins in moderately hypercholesterolemic men. Am J Clin Nutr 2000;71:1077.
35. Minamino T, Kitakaze M, Komamura K, et al. Activation of protein kinase C increases adenosine production in the hypoxic canine coronary artery through the extracellular pathway. Arterioscler Thromb Vasc Biol. 1995;15:2298.
36. Okajima F, Akbar M, Abdul Majid M, Sho K, Tomura H, Kondo Y. Genistein, an inhibitor of protein tyrosine kinase, is also a competitive antagonist for P1-purinergic (adenosine) receptor in FRTL-5 thyroid cells. Biochem Biophys Res Commun 1994;203:1488.
37. Pan W, Ikeda K, Takebe M, Yamori Y. Genistein, daidzen and glycitein inhibit growth and DNA synthesis of aortic smooth muscle cells from stroke-prone spontaneously hypertensive rats. J Clin Endocrinol Metab 2001;86:41.